The central science

CSE Bulletin: Suspensions - AWKN, BHCC, BZAM, GLOW, VTAL, JKPT, MEAL,VFI.X, STHZ

Retrieved on: 
水曜日, 5月 8, 2024
The central science, Policy, Politique, National instrument

Toronto, Ontario--(Newsfile Corp. - Le 8 mai/Mai 2024) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - Le 8 mai/Mai 2024) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3.
  • The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules.
  • For more information about Cease Trade Orders, visit the Canadian Securities Administrators Cease Trade Order database at www.securities-administrators.ca .
  • Les suspensions sont considérées comme des arrêts réglementaires au sens du Règlement 23-101 sur les règles de négociation.

CSE Bulletin: Suspensions - AWKN, BHCC, BZAM, GLOW, VTAL, JKPT, MEAL,VFI.X, STHZ

Retrieved on: 
水曜日, 5月 8, 2024
The central science, Policy, Politique, National instrument

Toronto, Ontario--(Newsfile Corp. - Le 8 mai/Mai 2024) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - Le 8 mai/Mai 2024) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3.
  • The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules.
  • For more information about Cease Trade Orders, visit the Canadian Securities Administrators Cease Trade Order database at www.securities-administrators.ca .
  • Les suspensions sont considérées comme des arrêts réglementaires au sens du Règlement 23-101 sur les règles de négociation.

CSE Bulletin: Suspensions - BIO, FABL, HMPS, IWIN

Retrieved on: 
火曜日, 5月 7, 2024
The central science, Policy, Politique, National instrument

Toronto, Ontario--(Newsfile Corp. - le 7 mai/May 2024) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - le 7 mai/May 2024) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3.
  • The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules.
  • En vigueur immédiatement, les sociétés suivantes sont suspendues conformément à la politique 3 du CSE.
  • Les suspensions sont considérées comme des arrêts réglementaires au sens du Règlement 23-101 sur les règles de négociation.

Alkeus Pharmaceuticals Announces Positive Interim Results Demonstrating No Signs of Disease Progression in Early-Stage Stargardt Disease Patients Treated with Gildeuretinol

Retrieved on: 
水曜日, 5月 8, 2024
UCLA, Stargardt disease, Stargardt, Research, Paratriathlon, Genetics, Retina, Patient, Human genetics, The central science, ABCA4, Clinical trial, Annual general meeting, ARVO, Vitamin A, Pharmaceutical industry

CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc. today announced the presentation of positive interim data from its TEASE-3 study demonstrating that early-stage Stargardt disease patients treated with gildeuretinol acetate showed no disease progression and remained asymptomatic for the duration of therapy ranging between two and six years.

Key Points: 
  • CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc. today announced the presentation of positive interim data from its TEASE-3 study demonstrating that early-stage Stargardt disease patients treated with gildeuretinol acetate showed no disease progression and remained asymptomatic for the duration of therapy ranging between two and six years.
  • Results were presented during the Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting being held May 5-9 in Seattle.
  • “These exciting results demonstrate the potential of gildeuretinol acetate to prevent vision loss in early-stage Stargardt patients,” said Leonide Saad, Ph.D., President and CEO of Alkeus Pharmaceuticals.
  • All of us working in our growing Alkeus team are committed to advancing research and having an impact on patients living with vision loss.

Vertex Energy Announces First Quarter 2024 Results and Optimization of Hydrocracking Capacity From Renewables to Conventional Production

Retrieved on: 
木曜日, 5月 9, 2024
Oil, Gas, Alternative Energy, Energy, Other Energy, Utilities, Gasoline, KPI, Economics, Public expenditure, Conversion, Engineering, Vertex, The central science

The Company also announced that it plans to optimize its hyrdrocracking capacity between conventional production and renewables production moving forward.

Key Points: 
  • The Company also announced that it plans to optimize its hyrdrocracking capacity between conventional production and renewables production moving forward.
  • The Company will host a conference call to discuss first quarter 2024 results today, at 9:00 A.M. Eastern Time.
  • During the second quarter of 2024, Vertex is pausing renewable fuels production and redirecting the hydrocracking unit to conventional fuels and products.
  • It will use that planned turnaround to load conventional catalyst and bring the unit out of turnaround in conventional service.

Decision Notice - CIRO Sanctions Patrick Joseph Conlin

Retrieved on: 
火曜日, 5月 7, 2024
CIRO, Dealer, Investment, Hearing, The central science, Financial adviser

a)      a permanent prohibition from conducting securities related business while in the employ of or associated with any Dealer Member of CIRO, and

Key Points: 
  • a)      a permanent prohibition from conducting securities related business while in the employ of or associated with any Dealer Member of CIRO, and
    b)      a fine of $75,000.
  • Patrick Conlin is also required to pay costs in the amount of $10,000.
  • The Notice of Hearing and Statement of Allegations which sets out the allegations are available at:
    The alleged violations occurred while Patrick Conlin was a Registered Representative with the London, Ontario branch of Investors Group Financial Services Inc. Patrick Conlin is no longer a registrant with a CIRO-regulated firm.
  • CIRO is committed to the protection of investors, providing efficient and consistent regulation, and building Canadians' trust in financial regulation and the people managing their investments.

CIRO to Hold a Disciplinary Hearing for James O'Reilly

Retrieved on: 
火曜日, 5月 7, 2024
CIRO, Investment, Hearing, The central science, Financial adviser

TORONTO, May 7, 2024 /CNW/ - A hearing has been scheduled before a hearing panel of the Canadian Investment Regulatory Organization (CIRO) pursuant to the Investment Dealer and Partially Consolidated Rules to set a date for a disciplinary hearing in the matter of James O'Reilly.

Key Points: 
  • TORONTO, May 7, 2024 /CNW/ - A hearing has been scheduled before a hearing panel of the Canadian Investment Regulatory Organization (CIRO) pursuant to the Investment Dealer and Partially Consolidated Rules to set a date for a disciplinary hearing in the matter of James O'Reilly.
  • The hearing is open to the public unless the panel orders otherwise.
  • The decision of the hearing panel will be made available at www.ciro.ca .
  • The hearing concerns allegations that James O'Reilly, directly or indirectly through corporate entities, used clients' funds in three real estate development projects, without his Dealer Member's knowledge.

Decision Notice - CIRO hearing panel reserves judgment on penalty in the matter of Joshua Emanuel Mifsud

Retrieved on: 
金曜日, 5月 3, 2024
CIRO, Judgement, Investment, The central science, Halton Hills, Property management

TORONTO, May 3, 2024 /CNW/ - A penalty hearing in the matter of Joshua Emanuel Mifsud was held before a hearing panel of the Canadian Investment Regulatory Organization (CIRO) on April 23, 2024.

Key Points: 
  • TORONTO, May 3, 2024 /CNW/ - A penalty hearing in the matter of Joshua Emanuel Mifsud was held before a hearing panel of the Canadian Investment Regulatory Organization (CIRO) on April 23, 2024.
  • After receiving an Agreed Statement of Facts and hearing submissions from CIRO Staff and Joshua Emanuel Mifsud concerning sanctions, the Hearing Panel reserved judgment and advised that they will issue their decision and written reasons in due course.
  • The Notice of Hearing and Statement of Allegations are available at:
    During the period described in the Notice of Hearing, Joshua Emanuel Mifsud conducted business in the Halton Hills, Ontario, area.
  • CIRO is committed to the protection of investors, providing efficient and consistent regulation, and building Canadians' trust in financial regulation and the people managing their investments.

Hearing Notice - CIRO schedules an interim appearance and a hearing date in the matter of Franco Caligiuri

Retrieved on: 
木曜日, 5月 2, 2024
CIRO, Sale, Dealer, Investment, Hearing, The central science, Financial adviser

VANCOUVER, BC, May 2, 2024 /CNW/ - An interim appearance and a hearing date have been scheduled before a hearing panel of the Canadian Investment Regulatory Organization (CIRO) under the Mutual Fund Dealer Rules in the matter of Franco Caligiuri.

Key Points: 
  • VANCOUVER, BC, May 2, 2024 /CNW/ - An interim appearance and a hearing date have been scheduled before a hearing panel of the Canadian Investment Regulatory Organization (CIRO) under the Mutual Fund Dealer Rules in the matter of Franco Caligiuri.
  • The hearing is open to the public unless the panel orders otherwise.
  • The decision of the hearing panel will be made available at www.ciro.ca .
  • The Notice of Hearing and Statement of Allegations, which set out the allegations, are available at:
    At all material times, Franco Caligiuri conducted business in the Burnaby, British Columbia area.

BAE Systems selected to build atmospheric composition instrument for NOAA's GeoXO constellation

Retrieved on: 
水曜日, 5月 1, 2024
BAE, Geostationary Extended Observations, TEMPO, Aircraft, Weather, NOAA, LON, GXS, Hospital, GEMS, Health, NASA, VIS, GXI, Ozone, Forecasting, Nitrogen dioxide, Science, Sulfur dioxide, ACX, BAE Systems, Movement, Formaldehyde, Temperature, Glyoxal, The central science, Communications satellite

BROOMFIELD, Colo., May 1, 2024 /PRNewswire/ -- BAE Systems (LON: BA) was selected by NASA to develop the Atmospheric Composition instrument (ACX) that will fly on the National Oceanic and Atmospheric Administration's (NOAA) Geostationary Extended Observations (GeoXO) satellite constellation.

Key Points: 
  • BROOMFIELD, Colo., May 1, 2024 /PRNewswire/ -- BAE Systems (LON: BA) was selected by NASA to develop the Atmospheric Composition instrument (ACX) that will fly on the National Oceanic and Atmospheric Administration's (NOAA) Geostationary Extended Observations (GeoXO) satellite constellation.
  • However, GeoXO will also provide novel, high-priority capabilities such as atmospheric composition, infrared sounding and ocean color observations to enhance forecasts and science benefits.
  • The ACX instrument builds on BAE Systems experience developing innovative atmospheric monitoring capabilities.
  • In addition to ACX, BAE Systems was also selected to build the GeoXO Sounder (GXS) instrument, which will measure atmospheric moisture, winds, and temperature to enhance weather prediction models and short-term severe weather forecasting among other applications.